Best Thyroid function tests (including T3, T4, TSH) diagnosticians in Turkey: TOP 40 doctors

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Mustafa Solak, M.D. is a medical doctor who graduated from Hacettepe University School of Medicine and has completed residencies at Istanbul Sisli Etfal Teaching and Research Hospital and a fellowship at Hacettepe University Cancer Institute. He specializes in Breast Cancer, Testicular Cancer, Ovarian Cancer, Lung Cancer, Head-Neck Cancer, and Gastrointestinal Cancers. He has also worked at the University of Texas MD Anderson Cancer Center, Hitit University Corum Training Hospital, and Medical Park Hospital.

Assoc. Prof. Nuri Alper Şahbaz is an experienced doctor with medical education from Istanbul University, Cerrahpaşa Faculty of Medicine, and scientific and clinical experience from Baylor College of Medicine and The University of Texas Medical School. He is specialized in endocrine surgery (thyroid, parathyroid, adrenal gland and neuroendocrine tumors) and has performed over 2000 successful surgeries in this area. He also specializes in laparoscopic and minimally invasive surgeries, as well as in diagnostic and therapeutic gastrointestinal system endoscopy.

Education:

• Degree: Faculty of Medicine, Trakya University, 2009
• Medical Specialty: Internal Medicine, Bakırköy Dr. Sadi Konuk Training and Research Hospital, 2010-2014
• Specialist Doctor: Internal Medicine, Kanuni Sultan Süleyman Training and Research Hospital, 2014-2019
• Specialist Doctor: Internal Medicine, Turkish Hospital Internal Medicine Clinic, Qatar, 2019-2020
• Specialist Doctor: Internal Medicine, Istanbul Medipol University Hospital Mega Hospital Internal Medicine Department, 2020-2024
• Associate Professor Doctor: Internal Medicine, Istanbul Medipol University Medipol Acıbadem Regional Hospital, 2024-Present.

Roles in Projects:

Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.

Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.

Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.

Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).

Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.

Education

• 1986-1989, Bursa High School, Bursa, Turkey
• 1989-1995, Istanbul University, Istanbul School of Medicine, Turkey
• 1999-2003, (Residency) Kadir Has University, School of Medicine, Department of Radiation Oncology, Istanbul, Turkey
• 2015, (Associate Professor) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2021, (Professor) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2024, Istanbul Medipol University, Department of Radiation Oncology, Istanbul, Turkey

Experience

• 1995-1999, Şişli Florence Nightingale Hospital, Istanbul, Cardiology Department
• 2003, Gayrettepe Florence Nightingale Hospital, Istanbul, Department of Radiation Oncology
• 2015, (Associate Professor in Radiation Oncology) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2021, (Professor in Radiation Oncology) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2024, Istanbul Medipol University, Department of Radiation Oncology, Istanbul, Turkey

Education and Experience

• 1992 - 1998, Gaziantep University, Faculty of Medicine
• 2002 – 2015, Cumhuriyet University, Faculty of Medicine, Department of Internal Medicine
• 2015 – 2024, Bağcılar Medipol Mega University Hospital
• 2024 – Present, Medipol Acıbadem Hospital

Specializations

Cancer Surgery

Pancreatic Surgery

Bile Duct Surgery

Bariatric Metabolic Surgery

Oncological Surgery

Breast Surgery

Gastric cancer

Colon cancer

Thyroid Cancer

Obesity Surgery

Diabetes Surgeries

Education

Ondokuz Mayıs University Faculty of Medicine (1991)

KTÜ Faculty of Medicine Farabi Hospital (Specialization.1998)

Istanbul University Çapa Faculty of Medicine (Laparoscopic Surgery Training, 2002)

Istanbul University Çapa Faculty of Medicine (Laparoscopic Antireflux Surgery Training, 2006)

Istanbul University Cerrahpaşa Faculty of Medicine (General Surgery Clinic Advance Laparoscopic Surgery, Laparoscopic Bariatric Surgery, Morbid Obesity and Oncological Cancer Surgery Training, 2010i)

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Dr. Tülay Omma, Associate Professor

Specialization: Endocrinology and Metabolic Diseases

Academic Background

• Medical Education: İnönü University, Faculty of Medicine (English Program), 1994–2001.
• Internal Medicine Residency: Haseki Training and Research Hospital, 2004–2010.
• Subspecialty in Endocrinology and Metabolism: Ankara Training and Research Hospital, 2013–2017.

Professional Experience

• Clinical Expertise: 
  • General Practitioner with administrative responsibilities, 2002–2004.
  • Specialist in Internal Medicine during mandatory service, 2010–2013.
  • Endocrinologist and Metabolic Disease Specialist at Ankara Training and Research Hospital (2017–2023).
  • Earned the title of Associate Professor in 2023, reflecting her academic and clinical excellence.
    Lokman Hekim Health Group 2023 (present) 

Scientific Contributions & Publications

• Research Output: 
  • Published over 20 articles in peer-reviewed international journals, with a strong focus on diabetes, thyroid disorders, and polycystic ovary syndrome.
  • Delivered numerous oral presentations and posters at national and international conferences.
• Citation Metrics: 
  • Total Citations: 166
  • H-index: 6
  • i10-index: 4

Awards & Recognitions

• Multiple prestigious accolades, including: 
  • Best Oral Presentation Award (2023): For groundbreaking research on COVID-19 vaccines and Graves’ Disease.
  • Best Poster Award (2021): For clinical insights into hypoparathyroidism in Turkey (HiPOPARATURK-NET Study).

Professional Memberships & Certifications

• Active member of leading organizations: 
  • European Society of Endocrinology (ESE) and its Young Endocrinologists & Scientists Committee (EYES).
  • Turkish Society of Endocrinology and Metabolism.
• Completed numerous advanced training programs, including certifications in clinical trials, biostatistics, and thyroid ultrasonography.

Clinical & Research Focus

Dr. Omma’s expertise spans:

• Diabetes management and its complications.
• Advanced thyroid disease diagnosis and treatment.
• Polycystic Ovary Syndrome (PCOS) and its metabolic implications.
• Investigating the relationship between diet and endocrine/metabolic disorders.

EDUCATION:

2014 ADNAN MENDERES UNIVERSITY FACULTY OF MEDICINE, CHILD HEALTH AND DISEASES, CHILD NEUROLOGY

2011 IZMIR EDUCATION AND RESEARCH HOSPITAL, CHILD HEALTH AND DISEASES

2011 Izmir Tepecik Education and Research Hospital, Child Health and Diseases

2004 DICLE UNIVERSITY, FACULTY OF MEDICINE

EXPERIENCE:

2018 Istanbul Medipol Hospital

2017 - 2018 Kartal Education and Research Hospital

2014 - 2016 Denizli State Hospital

2011 - 2014 Aydin Adnan Menderes University Faculty of Medicine Hospital

2006 - 2011 Izmir Tepecik Education and Research Hospital

2011Izmir Education and Research Hospital

EDUCATIONAL BACKGROUND

Medical Specialization YÜZÜNCÜ YIL UNIVERSITY

FACULTY OF MEDICINE/DEPARTMENT OF INTERNAL MEDICINE/DEPARTMENT OF PEDIATRICS

2/Feb/2009

Name of Thesis: Screening for hematuria and proteinuria in school age children (2008) Supervisor:(ŞÜKRÜ ARSLAN)

Undergraduate Education   SELÇUK UNIVERSITY

1997                      MERAM FACULTY OF MEDICINE /MERAM MEDICAL PRACTICE.

30/June/ 2003

Academic Duties

PROFESSOR           ISTANBUL MEDIPOL UNIVERSITY / FACULTY OF MEDICINE / DEPARTMENT OF INTERNAL MEDICAL SCIENCES 

2019

/ DEPARTMENT OF PEDIATRIC HEALTH AND DISEASES)

ASSOCIATE PROFESSOR    MEDIPOL UNIVERSITY / FACULTY OF MEDICINE / DEPARTMENT OF INTERNAL MEDICAL SCIENCES 

2014/-2019

/ DEPARTMENT OF PEDIATRIC HEALTH AND DISEASES)

ASSOCIATE PROFESSOR DÜZCE UNIVERSITY/FACULTY OF MEDICINE

2014/-2014

FACULTY MEMBER        DUZCE UNIVERSITY/FACULTY OF MEDICINE/DEPARTMENT OF INTERNAL 

2010/-2013

Supervised Theses 
Medical Specialization 
2022

MEDICAL SCIENCES/DEPARTMENT OF PEDIATRIC HEALTH AND DISEASES)

1. ATABAY CEM, (2022).  Determination of the frequency of adenotonsillar hypertrophy and serous otitis and their surgical prognosis in pediatric allergic rhinitis cases, Istanbul Medipol University->Faculty of Medicine->Department of Pediatric Health and Diseases (Completed)

Cemalettin Güne , (2013). Investigation of Bone Metabolism Changes in Children with Type 1 Diabetes Mellitus, 

1. DUZCE UNIVERSITY/FACULTY OF MEDICINE/DEPARTMENT OF INTERNAL MEDICAL SCIENCES/

DEPARTMENT OF CHILD HEALTH AND DISEASES/

Administrative Duties:

Chief Physician  ISTANBUL MEDIPOL UNIVERSITY/HEALTHCARE PRACTICE AND RESEARCH CENTER

2021

Works

Articles published in international peer-reviewed journals:

•  
• - CÖMERT   MURAT,Akgun  Cihangir,AKGÜN   AY  E  SERAP,OKUR   MESUT,GÜNDÜZ   MEHMET,TEMEL HAYRETT N  (2020).  Demographic  Characteristics   of   the  School-age   Children   With  Voiding Dysfunction,  and  Diagnostic Role  of  Ultrasound per  se..    Asian Pacific  Journal  of Health  Sciences,   6(1), 1-9. 
•  
• - OKUR MESUT,Erbey  Fatih,Kaya  Avni,Güven Ay  e  (2020). Van  Gölü  havzas nda 0–18  ya   grubu çocuklarda  Sitomegalovirus,  Rubella ve  Toksoplazma  seroprevalans .   Konuralp   T p   Dergisi,   4(1), 13-16. 

1. GÜNDÜZ  MEHMET,OKAN  MEL HA   AKSOY,  ENG L  AHMET   ZEK ,TEMEL   HAYRETT N,CÖMERT MURAT,OKUR  MESUT (2019).  The  relationship of  argyrophilic   proteins  of   the   nuclear?organized regions  and atopic  dermatitis   in  children.   Experimental   Dermatology,   28(11),  1309-1312.   
2. OKUR   MESUT,ERÖZ  RECEP,Bekta    Mehmet   Selçuk,Gül en   Süleyman,BAHADIR   ANZEL,Türker Yasin,GÜNE   CEMALETT N   (2016).   THE  RELATIONSHIP   BETWEEN   CONGENITAL  HEART   DEFECTS AND  e-NOS GENE  IN  DOWN SYNDROME..    Genetic  counseling (Geneva,  Switzerland),  27(3), 285-    293. 
3. Okan Meliha Aksoy, GÜNDÜZ MEHMET,  OKUR  MESUT, Akgun  Cihangir,  ES N  KÜBRA  (2016). Does maternal diet affect infantile colic?.  JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 29(19)-3141., Doi: 10.3109/14767058.2015.1115011 
4. Aksoy  Okan  Meliha,Gunduz   Mehmet,OKUR   MESUT,Akgun  Cihangir,ES  N   KÜBRA  (2015).   Does maternal  diet affect  infantile  colic?. The  Journal  of Maternal-Fetal   Neonatal  Medicine, 29(19), 3139-3141. 
5. Kaya Avni,OKUR  MESUT,Sal  Ertan,Peker Erdal,Köstü  Murat,TUNCER  O  UZ,K r mi  Ercan  (2014). Comparison of Cerebral Oximeter  and  Pulse Oximeter  Values  in the  first  72 hours  in  Premature, Asphyctic and Healthy Newborns. West Indian Medical Journal 
6. Uzun     Hakan,Gözkaya     Serçin,Ye  ildal     Nuray,OKUR     MESUT,ARSLANO   LU    LKNUR,KOCABAY KENAN,  enses  Dursun Ali  (2014).   The Prevalence  of  Goiter and  Hypothyroidism  among School   Children 6 Years after  Introduction of  a  Mandatory Salt  Iodination  Program in  a  Severely Iodine- Deficient  Area  of the  West  Black Sea  Region  of Turkey.   Journal  of Tropical  Pediatrics,  60(4), 318- 321. 
7. Özkan   Aybars,OKUR  MESUT,KAYA   MURAT,Kaya   Ertu rul,Küçük   Adem,Erba     Mesut,Kutlucan Leyla,Sahan   Leyla  (2013).   Sedoanalgesia   in  pediatric   daily   surgery..   International   journal   of clinical and experimental medicine, 6(7), 576-82. 
8. OKUR   MESUT,Erbey    Fatih,Yazicio  lu   Özlem,Çelik    Ali,Tükenmez    Bar  ,SÜNNETÇ O  LU MAHMUT,Gassalo   lu Mithat,Acar  Mehmet  Nuri (2013).   H1N1  influenza A  virus  Related Pneumonia     and Respiratory Failure. Indian Journal of Virology, 24(1), 85-89. 
9. OKUR    MESUT,ARSLAN    ÜKRÜ,GÜVEN    AHMET   SAM ,TEMEL    HAYRETT N,Bekta    Mehmet Selçuk,ÜSTYOL  LOKMAN (2013).  Determination  of  underlying   causes   in  asymptomatic,   early-stage renal  diseases  by dipstick  test..   Medicinski glasnik  :  official publication  of  the Medical  Association        of Zenica-Doboj Canton, Bosnia and Herzegovina, 10(1), 55-8. 
10. ERÖZ   RECEP,OKUR  MESUT,Özkan   Aybars,Berik   Özgür,GÜNE  CEMALETT  N   (2012).   Does   higher NORs expression affect  the developmental  stages  of Down  syndrome  infants?. Genetic  counseling (Geneva, Switzerland), 23(2), 249-53. )
11. OKUR MESUT,Özen   Semiha   Fatma,KOCABAY   KENAN,Çam  Kamil,Özkan   Aybars,Uzun   Hakan  (2012). The  effect  of maximum  voided  volume on  response  to desmopressin  therapy  in children  with   enuresis.. Journal of Nippon Medical School = Nippon Ika  Daigaku  zasshi, 79(4),  255-8.  
12. Uzun   Hakan,Alagöz    Demet,OKUR    MESUT,Dikici    Bünyamin,KOCABAY    KENAN,  enses    Dursun Ali,Özkan  Aybars,KAYA MURAT  (2012).   Do gastrointestinal  and  respiratory signs  and  symptoms  correlate with the  severity  of gastroesophageal  reflux?.  BMC Gastroenterology,  12(1)  (

Articles published in international peer-reviewed journals:

1. OKUR MESUT,Rüzgar Hacer,Erbey Fatih,Kaya  Avni  (2012). The  evaluation  of children  with monosymptomatic  nocturnal  enuresis for  attention  deficit and  hyperactivity  disorder.  International  Journal of Psychiatry in Clinical Practice, 16(3), 229-232. 
2. OKUR MESUT,Erbey  Fatih,Bekta   Mehmet  Selçuk,Kaya   Avni,Do   an  Murat,Acar   Mehmet   Nuri,Uzun Hakan  (2012).  Retrospective   clinical   and  laboratory   evaluation   of  children   with   brucellosis. Pediatrics International, 54(2), 215-218. 

B Articles published in national peer-reviewed journals:

1. Kaya Avni,Erbey Fatih,OKUR  MESUT,Sal Ertan,ÜSTYOL  LOKMAN,Bekta  Mehmet Selçuk  (2020).  Van Yöresinde 0-18  Ya  lar  Aras  ndaki  ÇocuklardaHepatit  B Virusu  Seropozitifli   i ve  A   lanma Durumu. Çocuk Enfeksiyon Dergisi, 5(4), 132-135. 

Technical Note, Case Presentation, Research Note, etc.

1. Vaka   Takdimi,  Do   an   Murat,Bekta    Mehmet  Selçuk,OKUR   MESUT,DO   AN    EK  BE   ZEHRA,CESUR YA  AR,ÇAKSEN  HÜSEY N,ÇA  AN   EREN  (2020).   Glutarik   Asidüri  Tip   2.   Arama  Sonuçlar  Web sonuçlar Türkiye Çocuk Hastal klar Dergisi, 6(3), 171-175. 
2. Vaka Takdimi, Kaya Avni,OKUR MESUT,AKBAYRAM S  NAN,AVCU  SERHAT,AÇIKGÖZ  MEHMET,Do an Murat,AKIL  MUHAMMET   (2020).  Acute   respiratory   distress  syndromerelated   to   near  hanging:   a case report. Turkish Archives of Pediatrics, 47(4), 302-304. 
3. Vaka Takdimi,  OKUR  MESUT,KÜÇÜK ADEM,ÖZKAN  AYBARS,KAYA  MURAT,TA KIN  AL  KEMAL (2020). Rectal Foreign-Body Retained by Self-Sexual Stimulation: A Case  of a  12  Year-Old Boy.  Journal(Yay n No: 6374953)
4. Vaka Takdimi, OKUR MESUT,Bekta  Mehmet Selçuk,TEMEL HAYRETT N,ÇAKSEN HÜSEY N,AÇIKGÖZ MEHMET,SAL  ERTAN  (2020). Biotidinase  Deficiency  Accompanied  by   Diffuse   Demyelination   and Cerebral Atrophy. European Journal of General Medicine, 9(3), 197-200. 
5. Vaka   Takdimi,  OKUR   MESUT,GÜNE   CEMALETT N,Özkan    Aybars,KAYA    MURAT,OKTAY    MURAT (2020).    Tekrarlayan akci   er  enfeksiyonu nedeniyle  ba   vuran bir  bronkojenik  kist olgusu.    Abant        T p Dergisi, 2, 43-45. 
6. Vaka Takdimi, Özkan Aybars,OKUR  MESUT,KAYA MURAT,KÜÇÜK  ADEM,SARI  LYAS (2020).  Necrotic Appendix  in Amyand’s  Hernia:  A  Case  Report.  International  Journal  of Clinical  Medicine,  4, 1-3.       
7. Vaka   Takdimi,  GÜN   EMRAH,AYAZ   NUSRET,UZUN  HAKAN,OKUR   MESUT,GÖNEN                                                                                                BAK,GÜNE CEMALETT N,SOYSAL ZEYNEB,KOCABAY KENAN (2020). Nefrolitiazisin E  lik Etti  i Nadir Bir Hastane Enfeksiyonu   EtkeniSphingomonas   Paucimobilis.    Cocuk  Enfeksiyon   Dergisi,   8(3),  125-127.   
8. Editöre  Mektup, Özkan   Aybars,KATRANCI   AL  OSMAN,OKUR   MESUT,KAYA   MURAT,KÜÇÜK  ADEM (2020).   Jel yak t na ba  l derin yüz yan     geli  en bir çocuk olgu.   Turk Pediatri Arsivi, 48(4), 350-            352. 
9. Vaka Takdimi, Akgun Cihangir,Kaya  Avni,AKBAYRAM  S NAN,TUNCER O  UZ,OKUR  MESUT,ARSLAN ÜKRÜ,ÖZEN SÜLEYMAN (2020). Lökositoklastik Vaskulit ve Membrano-proliferatif Glomerulonefrit

Birlikteli i: A case study Konuralp Tip Dergisi, 5(3), 58-61. 

1. Vaka Takdimi,  ÖZKAN  AYBARS,OKUR MESUT,KAYA  MURAT,KÜÇÜK   ADEM,UZUN  HAKAN   (2020). Apandisiti  taklit eden   intestinal  non-Hodgkin lenfoma.   Ça   da  T  p  Dergisi,  4(2),   100-110.   
2. Vaka Takdimi, Kaya Avni,AKIL MUHAMMET,TEMEL  HAYRETT N,OKUR  MESUT,Do an  Murat,PEKER ERDAL,ÜNER ABDURRAHMAN,B L C SAL M (2020). Akut  Bat  n Klini  i  ile Seyreden  Brusella:  ki Olgu Sunumu. Van T p Dergisi, 20(2), 81-83. 
3. Vaka   Takdimi,  Özkan   Aybars,KAYA   MURAT,OKUR  MESUT,KOCABAY   GÖNENÇ,KOCABAY   KENAN (2020).  Ventrikülo-Peritoneal    ant  Sonrasi Masif  Asiti  Taklit Eden  DevAbdominal  Psödokist.  DÜZCE     TIP DERG S , 15(2), 52-54. 
4. Vaka Takdimi,  Kaya   Avni,OKUR  MESUT,ÜSTYOL   LOKMAN,TEMEL   HAYRETT N,ÇAKSEN   HÜSEY  N (2020).  Acute  cyanide  poisoning after  eating  apricot pits:  a case report.    Turkish Archives  of Pediatrics, 47(2), 141-142. 
5. Editöre  Mektup, Erbey  Fatih,Rüzgar  Hacer,OKUR MESUT  (2020).    Risperidona ba  l   lökopeni ve  nötropeni  geli en  7  ya  nda  bir  olgu.   Anadolu  Psikiyatri  Dergisi, 12(3),  244-244.  
6. Vaka Takdimi,  Soysal  Zeyneb,OKUR  MESUT,ERÖZ   RECEP,Gün   Emrah,KOCABAY   KENAN,Be  ir   Fahri Halit (2015). MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH  SUBCORTICAL  CYSTS WITH HOMOZYGOUS MUTATION (C.448DELC, P.LEU150 SER FSX11) ON EXON 6 OF MLC1 GENE..  Genetic   counseling (Geneva, Switzerland), 26(2), 233-6. 

Technical Note, Case Presentation, Research Note, etc.

1. Vaka Takdimi,  Özkan  Aybars,Bozkurter  Çil Asudan  Tu   çe,KAYA MURAT,Etçio   lu   nci,OKUR MESUT (2015).  Late   Presenting  Bochdalek   Hernia   With  Gastric   Perforation.   Pediatric  Emergency   Care, 31(1), 47-49. 
2. Vaka   Takdimi,  Özkan   Aybars,OKUR   MESUT,KAYA  MURAT,Büyükkaya  Ramazan,Katranc   Ali Osman,Küçük Adem (2013). An easy technique for removal  of  knotted catheter  in  the bladder: percutaneous  suprapubic   cystoscopic   intervention..     International   journal  of   clinical   and experimental medicine, 6(7), 603-5. 
3. Vaka Takdimi,  Özkan  Aybars,OKUR MESUT,KAYA   MURAT,Küçük   Adem  (2013).   A   Case  of Bronchogenic  Cyst  Mimicking Foreign  Body   Aspiration.  Pediatric   Emergency   Care,  29(7),   833-835. 
4. Vaka   Takdimi,  OKUR   MESUT,ERÖZ    RECEP,Mundlos    Stefan,  enses    Dursun    Ali,ÜLGEN   TEMEL ESRA, smailler  Zeynep  Bengül,ÖZÇEL K  DERYA (2012).   EEC  syndrome with  a  de novo  mutation    (c.953g gt  a)  on exon  7  of P63  gene:  a case report.    Genetic counseling  (Geneva,  Switzerland), 23(4), 483-5. 
5. Vaka Takdimi, Uslu Mustafa,OKUR MESUT,Gönen bak  (2012).  Low-grade Osteomyelitis  of  the Fifth Metatarsal  with  Possible Concomitant  Freiberg’s  Disease of  the  Metatarsal Head.    The  Journal of      Foot and Ankle Surgery, 51(6), 798-800. 
6. Vaka Takdimi,  Turan  Hakan,OKUR MESUT,Kaya  Ertu  rul,Gün  Emrah,Alia   ao   lu  Cihangir   (2012). Allergic  contact dermatitis  to  para-phenylenediamine  in a  tattoo:   a case report.   Cutaneous  and Ocular Toxicology, 32(2), 185-187. 
7. Vaka   Takdimi,   OKUR    MESUT,Turan    Hakan,Özkan    Aybars,Güne    Cemalettin,KOCABAY    KENAN (2012).    An extremely  rare  cause of  bruising  in children:  Autoerithrocyte  Sensitization Syndrome.  Turkish Journal of Hematology, 29(2), 201-203. 
8. Vaka Takdimi,  Öz  ahin  Mustafa,Uslu   Mustafa,  nanmaz  Erkan,OKUR   MESUT   (2012).  Bilateral Congenital Undescended Scapula (Sprengel  Deformity). American  Journal  of Physical  Medicine Rehabilitation, 91(4), 374 
9. Editöre  Mektup, Kaya  Avni,Ta   k  n  Gökmen Alpaslan,OKUR  MESUT,Bekta    Mehmet Selçuk,ÇAKSEN  HÜSEY  N (2012).  Infantile  Masturbation in   Monozygotic   Twins.  The   Journal   of  Sexual   Medicine, 9(1), 331-332. 
10. Editöre  Mektup, Kaya  Avni,OKUR  MESUT (2012).   Bee  sting in  mother  and urticarial  rash  in her    baby.. Indian pediatrics, 49(6), 499 
11. Vaka Takdimi, OKUR MESUT,Erbey Fatih,Bulut Gülay  (2011).  Phyllodes Tumor  in  a 16-Year-Old  Girl. Pediatric Hematology and Oncology, 28(5), 444-446. 
12. Vaka   Takdimi,  OKUR   MESUT,Özkan   Aybars,GÜNE  CEMALETT  N,KAYA   MURAT,KOCABAY   KENAN (2011).   Case of isolated thrombocytopenia due to cobalamin deficiency..   International journal of   hematology, 94(5), 488-90., 
13. Vaka Takdimi,  Kaya   Avni,Aç kgöz   Mehmet,ÜSTYOL   LOKMAN,Avcu  Serhat,Sal   Ertan,OKUR MESUT,ÇAKSEN HÜSEY N (2010). A case of  acute  disseminated encephalomyelitis  mimicking leukodystrophy.. The Kurume medical journal, 
14. Vaka Takdimi,  Y  lmaz Cahide,OKUR   MESUT,Geylani   Hadi,ÇAKSEN  HÜSEY  N,TUNCER  O   UZ,ATA BÜLENT  (2010).  Chronic  mercury  poisoning: Report  of  two siblings.   Indian  Journal of  Occupational  and Environmental Medicine, 14(1), 17 
15. Vaka    Takdimi,   ÇAKSEN    HÜSEY N,Bartsch    Oliver,OKUR    MESUT,TEMEL    HAYRETT N,Aç kgöz  Mehmet,Y lmaz   Cahide   (2009).  Rubinstein-Taybi   syndrome   and  CREBBP   c.201   202delTA  mutation: a  case  presenting with   varicella   meningoencephalitis..   Genetic  counseling   (Geneva,   Switzerland), 

Non-Academic Experience

2009-2010        Specialist Doctor          VAN GYNAECOLOGY AND PEDIATRIC HOSPITAL (State)

2017: Oticon Medical Scientific Center Copenhagen Denmark.
2016: ICLO Teaching Center New Endoscopic Approaches to Lateral Skull Base, Inner Ear and Cerebello-Pontine Angle, Verona Italy
2016: World Hearing Center, Institute of Physiology and Pathology of Hearing, Warsaw,Poland
2015: Cochlear Science and Research Center Berlin Germany.
2014: Cochlear implant Center Medel Company Innsburck, Austria.
2014: Hannover Medical School. Clinic for Laryngology, Rhinology and Otology, Hannover, Germany
2014: Academy of Hearing Aid Acoustics (Akademie für Hörgerate-Akustik), Lübeck, Germany.
2013: International European Sialendoscopy Training Center, Geneva, Switzerland.
2012: University clinic of ORL, Head and Neck Surgery, klinikum der Universitat, Munchen, Germany.
2012: University clinic of ORL, Head and Neck Surgery, Bern, Switzerland.
2011: University clinic of ORL, Head and Neck Surgery, klinikum der Universitat, Munchen, Germany.
2007: The Ohio State University, Medical Faculty, Department of Otolaryngology, Division of Otology and Neurotology. Columbus, Ohio, USA.
2006: University of Würzburg, Department of Otolaryngology, Division of Otology and Neurotology. Würzburg, Germany.
1999-2003 İnönü Üniversitesi Tıp Fakültesi Kulak Burun Boğaz Anabilim Dalı
1993-1999 İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi

Turkish Otorhinolaryngology and Head and Neck Surgery Association

Turkish Otorhinolaryngology and Head and Neck Surgery Foundation

Turkish Rhinology Society

Tigris-Euphrates Basin Otorhinolaryngology and Head and Neck Surgery Association

Gaziantep Otorhinolaryngology Association

Turkish Otorhinolaryngology and Head and Neck Surgery Qualification Board

Turkish Otology Association

Malatya Otorhinolaryngology Association

American Academy of Otolaryngology Head and Neck Surgery

Mediterranean Society of Otology and Audiology

International Vertigo Association

Experience 

• 2016 - 2017

İSTİNYE UNIVERSITY FACULTY OF MEDICINE

• 2016 - 2017

Liv Hospital

• 2016 - 2017

Liv Hospital Ulus

• 2015 - 2016

Acıbadem Bodrum Hospital

• 2014 - 2015

Tatvan State Hospital

• 2013 - 2015

Tatvan State Hospital

• 2012 - 2013

CLEVELAND CLINIC

• 2007 - 2014

Dokuz Eylul University Faculty of Medicine

Education 

• 2013

DOKUZ EYLÜL UNIVERSITY FACULTY OF MEDICINE, FACULTY OF MEDICINE/DEPARTMENT OF SURGICAL MEDICAL SCIENCES/DEPARTMENT OF GENERAL SURGERY

• 2013

Dokuz Eylül University, General Surgery

• 2007

AKDENİZ UNIVERSITY, FACULTY OF MEDICINE

• 2007

International Peer-Reviewed Journal Articles:

Title: The impact of sarcopenia on morbidity and long-term survival among patients with peritoneal metastases of colorectal origin treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a 10-year longitudinal analysis of a single-center experience.

• Authors: AĞALAR CİHAN, SÖKMEN SELMAN, ARSLAN ÖZŞAHİN NACİYE ÇİĞDEM, ALTAY CANAN, BAŞARA AKIN IŞIL, CANDA ARAS EMRE, OBUZ FUNDA
• Journal: Techniques in Coloproctology
• Year: 2020
• Volume: 24(4)
• Pages: 301-308
• DOI: 10.1007/s10151-020-02159-z
• Publication Number: 6776368

Title: Randomized controlled trial of 8 weeks’ vs 12 weeks’ interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer.

• Authors: Terzi Cem, Bingül Mustafa, ARSLAN NACİYE ÇİĞDEM, ÖZTÜRK ERSİN, CANDA ARAS EMRE, IŞIK ÖZGEN, YILMAZLAR AHMET TUNCAY, OBUZ FUNDA, Görken Birkay, KURT MERAL, ÜNLÜ ŞADİYE MEHTAT, UĞRAŞ NESRİN, Kanat Özkan, ÖZTOP İLHAN
• Journal: Colorectal Disease
• Year: 2020
• Volume: 22(3)
• Pages: 279-288
• DOI: 10.1111/codi.14867
• Publication Number: 6012919

Title: The effect of fibrin glue in preventing staple-line leak after sleeve gastrectomy: an experimental study in rats.

• Authors: ÖZDENKAYA YAŞAR, OLMUŞÇELİK OKTAY, BASIM PELİN, SAKA BURCU, ARSLAN NACİYE ÇİĞDEM
• Journal: Acta Cirurgica Brasileira
• Year: 2019
• Volume: 34(8)
• Publication Number: 5242669

Title: Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.

• Authors: CANDA ARAS EMRE, ARSLAN NACİYE ÇİĞDEM, Terzi Cem, Sokmen Selman, YAVUZŞEN TUĞBA, Ozkardesler Sevda, Unlu Mehtat, OBUZ FUNDA, FÜZÜN MEHMET
• Journal: World Journal of Surgical Oncology
• Year: 2018
• Volume: 16(1)
• Pages: 70-74
• DOI: 10.1186/s12957-018-1369-7
• Publication Number: 4863133

Title: Magnetic resonance-based pelvimetry and tumor volumetry can predict surgical difficulty and oncologic outcome in locally advanced mid–low rectal cancer.

• Authors: Atasoy Gulsen, ARSLAN NACİYE ÇİĞDEM, Elibol Funda, SAĞOL ÖZGÜL, OBUZ FUNDA, SÖKMEN SELMAN
• Journal: Surgery Today
• Year: 2018
• Volume: 48(12)
• Pages: 1040-1051
• DOI: 10.1007/s00595-018-1690-3
• Publication Number: 4863005

Title: Is advanced age a hesitation for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer?

• Authors: Terzi Cem, Sokmen Selman, ARSLAN NACİYE ÇİĞDEM, Ozkardesler Sevda, DURAL CEMIL, OBUZ FUNDA, CANDA ARAS EMRE, GÖKTÜRK ÜMIT KELEŞTEN
• Journal: International Journal of Surgery
• Year: 2018
• Volume: 51
• Pages: 156-160
• DOI: 10.1016/j.ijsu.2018.01.010
• Publication Number: 4855751

Contributions to Conferences:

Title: Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: A single-center experience.

• Authors: CANDA ARAS EMRE, Sokmen Selman, Terzi Cem, ARSLAN NACİYE ÇİĞDEM, OBUZ FUNDA
• Conference: European Society of Surgical Oncology (ESSO) Congress
• Year: 2018
• Location: Budapest, Hungary

Title: Predictive factors for conversion to open surgery in laparoscopic colorectal surgery.

• Authors: ARSLAN NACİYE ÇİĞDEM, Terzi Cem, Sokmen Selman, CANDA ARAS EMRE, OBUZ FUNDA
• Conference: European Association for Endoscopic Surgery (EAES) Congress
• Year: 2017
• Location: Frankfurt, Germany

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)